Veeva Systems Retained Earnings (Accumulated Deficit) 2012-2025 | VEEV
Veeva Systems retained earnings (accumulated deficit) from 2012 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Veeva Systems retained earnings (accumulated deficit) for the quarter ending January 31, 2025 were $3.455B, a 26.06% increase year-over-year.
- Veeva Systems retained earnings (accumulated deficit) for 2025 were $3.455B, a 26.06% increase from 2024.
- Veeva Systems retained earnings (accumulated deficit) for 2024 were $2.74B, a 23.74% increase from 2023.
- Veeva Systems retained earnings (accumulated deficit) for 2023 were $2.215B, a 28.24% increase from 2022.
| Veeva Systems Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025 | $3,455 |
| 2024 | $2,740 |
| 2023 | $2,215 |
| 2022 | $1,727 |
| 2021 | $1,300 |
| 2020 | $920 |
| 2019 | $619 |
| 2018 | $389 |
| 2017 | $213 |
| 2016 | $143 |
| 2015 | $89 |
| 2014 | $49 |
| 2013 | $25 |
| 2012 | $6 |
| 2011 | $0 |
| Veeva Systems Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-01-31 | $3,455 |
| 2024-10-31 | $3,259 |
| 2024-07-31 | $3,073 |
| 2024-04-30 | $2,902 |
| 2024-01-31 | $2,740 |
| 2023-10-31 | $2,593 |
| 2023-07-31 | $2,458 |
| 2023-04-30 | $2,346 |
| 2023-01-31 | $2,215 |
| 2022-10-31 | $2,026 |
| 2022-07-31 | $1,918 |
| 2022-04-30 | $1,827 |
| 2022-01-31 | $1,727 |
| 2021-10-31 | $1,630 |
| 2021-07-31 | $1,524 |
| 2021-04-30 | $1,415 |
| 2021-01-31 | $1,300 |
| 2020-10-31 | $1,197 |
| 2020-07-31 | $1,100 |
| 2020-04-30 | $1,006 |
| 2020-01-31 | $920 |
| 2019-10-31 | $853 |
| 2019-07-31 | $771 |
| 2019-04-30 | $692 |
| 2019-01-31 | $619 |
| 2018-10-31 | $548 |
| 2018-07-31 | $484 |
| 2018-04-30 | $434 |
| 2018-01-31 | $389 |
| 2017-10-31 | $321 |
| 2017-07-31 | $287 |
| 2017-04-30 | $249 |
| 2017-01-31 | $213 |
| 2016-10-31 | $190 |
| 2016-07-31 | $169 |
| 2016-04-30 | $156 |
| 2016-01-31 | $143 |
| 2015-10-31 | $126 |
| 2015-07-31 | $115 |
| 2015-04-30 | $102 |
| 2015-01-31 | $89 |
| 2014-10-31 | $76 |
| 2014-07-31 | $65 |
| 2014-04-30 | $56 |
| 2014-01-31 | $49 |
| 2013-10-31 | $42 |
| 2013-07-31 | |
| 2013-04-30 | |
| 2013-01-31 | |
| 2012-10-31 | |
| 2012-01-31 | $6 |
| 2011-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $39.307B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $13.112B | 136.23 |
| Tempus AI (TEM) | United States | $10.781B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.503B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.415B | 68.98 |
| Privia Health (PRVA) | United States | $3.036B | 207.50 |
| Enovis (ENOV) | United States | $2.041B | 11.38 |
| Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
| Schrodinger (SDGR) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.529B | 0.00 |
| Omnicell (OMCL) | United States | $1.315B | 23.21 |
| Azenta (AZTA) | United States | $1.223B | 56.83 |
| 10x Genomics (TXG) | United States | $1.125B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Talkspace (TALK) | United States | $0.500B | 149.50 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.368B | 816.67 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.147B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |